13 completed, 7 recruiting, 3 active not recruiting, 3 unknown. 10 Not applicable, 6 Phase 2, 5 Phase 1, 1 Phase 4.
Follow HPV-Related Cervical Carcinoma: new trials by email Literature Review of HPV-Related Cervical Carcinoma trials Research Report on HPV-Related Cervical Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes ctDNA test, Pembrolizumab - HPV-Related Carcinoma, Uterine Cervical Cancer | Phase 2 | Recruiting | Instituto do Cancer do Estado de São Paulo | 150 | 2025-03-14 | 2025-12-24 |
| A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer Two IM injections Lenti-HPV-07, One IM injection Lenti-HPV-07 - HPV-Related Cervical Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma | Phase 1 / Phase 2 | Recruiting | Theravectys S.A. | 72 | 2024-08-08 | 2026-02-02 |
| A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors TSC-204-A0201, TSC-204-C0702, TSC-200-A0201 - Head and Neck Cancer, Cervical Cancer | Phase 1 | Active not recruiting | TScan Therapeutics, Inc. | 840 | 2024-05-06 | 2025-11-17 |
| Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer. VB10.16, Atezolizumab Injection [Tecentriq], Placebo - HPV-Related Cervical Carcinoma, HPV-Related Malignancy | Phase 2 | Withdrawn | Nykode Therapeutics ASA | 2024-04-18 | 2024-09-20 | |
| Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples Colli-Pee 20mL device with UCM, Evalyn Brush - Uterine Cervical Neoplasm, Uterine Cervical Dysplasia | Not applicable | Recruiting | Universiteit Antwerpen | 100 | 2024-03-28 | 2024-09-19 |
| Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women FluBHPVE6E7, Placebo - HPV Infection, HPV-Related Cervical Carcinoma | Phase 1 | Recruiting | BlueSky Immunotherapies GmbH | 20 | 2023-09-12 | 2025-02-14 |
| Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection CO2 - HPV-Related Cervical Carcinoma, Low-Grade Squamous Intraepithelial Lesions | Not applicable | Recruiting | First Affiliated Hospital of Wenzhou Medical University | 40 | 2023-09-11 | 2025-05-13 |
| Self-collected Vaginal and Urine Samples in HIV-positive Women Self-sampling for HPV infection - HIV Infections, HPV-Related Cervical Carcinoma | Completed | University of Aarhus | 502 | 2023-05-29 | 2024-08-28 | |
| Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial Colli-Pee Small Volumes, Evalyn Brush - Cervix Cancer, Cervical Intraepithelial Neoplasia | Not applicable | Active not recruiting | Universiteit Antwerpen | 48000 | 2023-05-25 | 2025-06-13 |
| Dry Run of the ScreenUrSelf Trial Colli-Pee Small Volumes, Evalyn Brush - Cervical Cancer, Cervical Intraepithelial Neoplasia | Not applicable | Completed | Universiteit Antwerpen | 38 | 2023-04-10 | 2023-08-18 |
| HPV Immunological Markers of Cervical Persistent Infection and Oncogenesis HPV-Related Cervical Carcinoma | Unknown | Fondazione IRCCS Policlinico San Matteo di Pavia | 120 | 2023-03-08 | 2024-11-05 | |
| E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers E7 TCR-T cells, Aldesleukin - Cervical Cancer, Throat Cancer | Phase 2 | Recruiting | Christian Hinrichs | 20 | 2023-03-07 | 2026-06-12 |
| This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols. Tumor Profiling - Head and Neck Cancer, Melanoma | Terminated | Repertoire Immune Medicines | 22 | 2021-05-05 | 2022-12-06 | |
| Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial Usual Care, Education, Direct Mail - Uterine Cervical Neoplasm, Uterine Neoplasms | Not applicable | Completed | Kaiser Permanente | 32771 | 2020-11-20 | 2023-09-18 |
| Detecting HPV DNA in Anal and Cervical Cancers Radiation Treatment With or Without Chemotherapy, Blood Sample Collection, HPV Genotyping (HPV DNA Test) - Cervical Cancer, Anal Cancer | Recruiting | University of Chicago | 20 | 2020-10-06 | 2026-03-04 | |
| CASUS: Validation for Detection of Precursor Lesions Colli-Pee Small Volumes (10 mL) device - Cervical Cancer, Cervical Intraepithelial Neoplasia | Not applicable | Completed | Universiteit Antwerpen | 332 | 2020-08-20 | 2022-06-15 |
| Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) Biological/Vaccine: 11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha), 9-valent HPV vaccine（Gardasil 9） - HPV Infection, HPV-Related Cervical Carcinoma | Phase 2 | Completed | National Vaccine and Serum Institute, China | 480 | 2020-06-20 | 2022-05-06 |
| A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years 11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha), Placebo - HPV Infection, HPV-Related Cervical Carcinoma | Phase 1 | Completed | National Vaccine and Serum Institute, China | 90 | 2019-09-07 | 2021-11-24 |
| CASUS: Improved and Quality Assured Collection of First-void Urine Colli-Pee® (FV5000 and Small Volumes) - Cervical Cancer, Cervical Intraepithelial Neoplasia | Not applicable | Completed | Universiteit Antwerpen | 25 | 2019-07-30 | 2020-07-21 |
| Knowledge and Attitudes Towards Human Papillomavirus Infections and HPV Vaccination knowledge questioannaire - HPV-Related Cervical Carcinoma | Completed | University Hospital, Geneva | 600 | 2019-04-01 | 2019-09-26 |
Showing 20 of 28. Sign in to see all of them.
Uterine Cervical Neoplasms (15) · Uterine Cervical Dysplasia (7) · Papillomavirus Infections (5) · Head and Neck Neoplasms (3) · Neoplasm Metastasis (3) · Anus Neoplasms (2) · Melanoma (2) · Neoplasms (2) · Oropharyngeal Neoplasms (2) · Anal Canal Carcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Genital Neoplasms, Female (1) · HIV Infections (1) · Inflammatory Bowel Diseases (1) · Neoplasms by Site (1)
Genital Diseases (20) · Urogenital Diseases (20) · Female Urogenital Diseases (16) · Female Urogenital Diseases and Pregnancy Complications (16) · Genital Diseases, Female (16) · Neoplasms (16) · Neoplasms by Site (15) · Uterine Cervical Diseases (15) · Uterine Diseases (15) · Genital Neoplasms, Female (14) · Urogenital Neoplasms (14) · Uterine Neoplasms (14) · Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Precancerous Conditions (7)
Adoptive Transfer (1) · Biological Products (1) · Drug Therapy (1) · Educational Status (1) · Human Papillomavirus DNA Tests (1) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1) · Positron-Emission Tomography (1) · Radiotherapy (1) · Restraint, Physical (1) · TG4001 vaccine (1) · Thrombin Time (1) · Tomography, X-Ray Computed (1) · aldesleukin (1) · atezolizumab (1) · avelumab (1)
Universiteit Antwerpen (5) · National Vaccine and Serum Institute, China (2) · University of Aarhus (2) · BlueSky Immunotherapies GmbH (1) · Christian Hinrichs (1) · Dr. Faizan Awan (1) · First Affiliated Hospital of Wenzhou Medical University (1) · Fondazione IRCCS Policlinico San Matteo di Pavia (1) · Global Alliance to Immunize Against AIDS Vaccine Foundation (1) · Institut d'Investigació Biomèdica de Bellvitge (1) · Instituto Nacional de Salud Publica, Mexico (1) · Instituto do Cancer do Estado de São Paulo (1) · Kaiser Permanente (1) · Nykode Therapeutics ASA (1) · Repertoire Immune Medicines (1)
United States (8) · Belgium (5) · China (4) · Spain (2) · Brazil (1) · Denmark (1) · France (1) · Guinea-Bissau (1) · Italy (1) · Mexico (1) · Slovakia (1) · Switzerland (1) · United Kingdom (1)
Pierre Van Damme, MD, PhD (4) · Alex Vorsters, Ir, PhD (2) · Severien Van Keer, PhD (2) · Amelia Acera, Dra. (1) · Anne De Groot, MD (1) · Barbara Gardella, MD (1) · Beverly B Green, MD, MPH (1) · Christian S Hinrichs, MD (1) · Christina Son, MD (1) · David Spriggs, MD (1) · Dawn Pinchasik, MD (1) · Faizan A Awan, MBChB MRCGP (1) · Maria DP Estevez Diz, Doctor (1)
PMID 19524035, PMID 23618600, PMID 26687616, PMID 29851256, PMID 30048762, PMID 30122563, PMID 30989655, PMID 31306313, PMID 32835877, PMID 33538338, PMID 35288319, PMID 37308042, PMID 37506588, PMID 38015219, PMID 39934916, PMID 39981930, PMID 40590686, PMID 41067140, PMID 41276263
R01CA240375 (1), U01CA287904 (1)